Literature DB >> 14610365

Protective effects of N-acetylcysteine and selenium against doxorubicin toxicity in rats.

Eun-sung Park1, Sun-don Kim, Min-hye Lee, Heung-shik S Lee, In-se Lee, Je-kyung Sung, Yeo-sung Yoon.   

Abstract

To investigate the neutralizing effect of N-acetylcysteine (NAC) and selenium (Se) against doxorubicin (DOX) toxicity in rats, NAC (140 mg/kg, p.o.) and Se (0.5 mg/kg, p.o.) were administered for 2 days before DOX injection and then 3 times a week. Cell viability and the level of lipid peroxidation were examined in cultured-rat astrocytes. Severe morphologic changes in the kidney of DOX group; thickening of Bowmans capsule, presence of multifocal tubular casts were observed, but not in the other treated groups. Vacuoles in some hepatic cells and focal aggregation of stellate macrophages were also detected in DOX group, but not in the other treated groups. However, the severe inhibition of spermatogenesis was found in all treated groups. The cell viability of DOX (10 mg/ml) treated group and NAC (5 mM) or Se (0.001 mg/ml) combined-treated group was 52.5-/+2.0 %, 85.3-/+4.5 % and 75.5-/+1.6 %, respectively. In MDA (malondialdehyde) assay, the level of lipid peroxidation on DOX (10 mg/ml), NAC (5 mM) and Se (0.001 mg/ml) was 0.77-/+0.06, 0.35-/+0.06 and 0.54-/+0.11 nmol/mg protein, respectively. Thus, it is known that NAC and Se have protective effects in kidney and liver but not in the testes. Morphological change was not detected in brain and heart in all groups for experiment period. From this in vitro study, it is known that NAC and Se protect well the astrocytes against DOX induced-cell damage.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14610365

Source DB:  PubMed          Journal:  J Vet Sci        ISSN: 1229-845X            Impact factor:   1.672


  9 in total

1.  Proanthocyanidins produce significant attenuation of doxorubicin-induced mutagenicity via suppression of oxidative stress.

Authors:  Sabry M Attia; Saleh A Al-Bakheet; Nouf M Al-Rasheed
Journal:  Oxid Med Cell Longev       Date:  2010-11-01       Impact factor: 6.543

2.  Increased Migratory and Activation Cell Markers of Peripheral Blood Lymphocytes in an Experimental Model of Nephrotic Syndrome.

Authors:  Wagner de Fátima Pereira; Gustavo Eustáquio Alvim Brito-Melo; Cláudia Martins Carneiro; Dirceu de Sousa Melo; Karine Beatriz Costa; Fábio Lourenço Tadeu Guimarães; Etel Rocha-Vieira; Érica Leandro Marciano Vieira; Ana Cristina Simões e Silva
Journal:  Mediators Inflamm       Date:  2015-05-07       Impact factor: 4.711

3.  Evaluation of antioxidant and cytoprotective activities of Artemisia ciniformis extracts on PC12 cells.

Authors:  Mahdi Mojarrab; Sajjad Nasseri; Leila Hosseinzadeh; Farah Farahani
Journal:  Iran J Basic Med Sci       Date:  2016-04       Impact factor: 2.699

4.  Mitoxantrone is More Toxic than Doxorubicin in SH-SY5Y Human Cells: A 'Chemobrain' In Vitro Study.

Authors:  Daniela Almeida; Rita Pinho; Verónica Correia; Jorge Soares; Maria de Lourdes Bastos; Félix Carvalho; João Paulo Capela; Vera Marisa Costa
Journal:  Pharmaceuticals (Basel)       Date:  2018-05-05

5.  Oxypeucedanin and isoimperatorin extracted from Prangos ferulacea (L.) Lindl protect PC12 pheochromocytoma cells from oxidative stress and apoptosis induced by doxorubicin.

Authors:  Fereshteh Jalilian; Maryam Moieni-Arya; Leila Hosseinzadeh; Yalda Shokoohinia
Journal:  Res Pharm Sci       Date:  2021-11-11

6.  ΔNp63 targets cytoglobin to inhibit oxidative stress-induced apoptosis in keratinocytes and lung cancer.

Authors:  A Latina; G Viticchiè; A M Lena; M C Piro; M Annicchiarico-Petruzzelli; G Melino; E Candi
Journal:  Oncogene       Date:  2015-06-22       Impact factor: 9.867

7.  N-acetylcysteine potentiates doxorubicin-induced ATM and p53 activation in ovarian cancer cells.

Authors:  Gabriella Brum; Thomas Carbone; Eric Still; Vendita Correia; Kevin Szulak; David Calianese; Charles Best; Garret Cammarata; Katelyn Higgins; Fang Ji; Wen Di; Yinsheng Wan
Journal:  Int J Oncol       Date:  2012-10-26       Impact factor: 5.650

8.  A Synthetic Aptamer-Drug Adduct for Targeted Liver Cancer Therapy.

Authors:  Thu Le Trinh; Guizhi Zhu; Xilin Xiao; William Puszyk; Kwame Sefah; Qunfeng Wu; Weihong Tan; Chen Liu
Journal:  PLoS One       Date:  2015-11-02       Impact factor: 3.240

9.  Osthole attenuates doxorubicin-induced apoptosis in PC12 cells through inhibition of mitochondrial dysfunction and ROS production.

Authors:  Yalda Shokoohinia; Leila Hosseinzadeh; Maryam Moieni-Arya; Ali Mostafaie; Hamid-Reza Mohammadi-Motlagh
Journal:  Biomed Res Int       Date:  2014-06-12       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.